Cybersecurity for Life Sciences
Iliomad Health Data offers specialised cybersecurity services for organisations across the life sciences sector. The digitisation of health and research – from cloudbased genomic analysis and laboratory automation to AIdriven drug discovery – means sensitive data and critical systems are now highvalue targets. Recent industry reports note that lifescience companies are grappling with rapidly expanding cyber threats that can affect system availability, data integrity and confidentiality . Our mission is to help you prevent, detect and respond to these threats while meeting demanding regulatory standards.
The stakes are high: cyber incidents can expose patient health information and intellectual property, causing thirdparty vulnerabilities to become firstparty liability . Threat actors exploit ransomware, supplychain weaknesses and software errors , and such incidents can halt clinical trials, disable medical equipment and erode trust. To help protect your patients, your research and your reputation, Iliomad Health Data delivers endtoend cybersecurity expertise tailored to biotech, medtech and research organisations.
Why Cybersecurity Is Essential for Your Organisation
Protect patient safety and intellectual property
Lifesciences organisations increasingly depend on digital devices and data flows. Ransomware attacks have become a permanent feature of the threat landscape and have increased significantly against healthcare and lifescience providers, with the World Health Organization reporting a fivefold increase in attacks in 2020 . A single cyber incident can compromise patient safety, delay treatments, and expose valuable research and manufacturing knowhow. Proactive security measures safeguard both patients and the intellectual property that underpins your competitive advantage.
Adoption of AI/ML, cloud platforms and IoT devices accelerates research but also expands the attack surface . Machinelearning tools process sensitive clinical data; IoT devices collect patientlevel measurements; and cloud services store genomic and trial data. Without strong security, data integrity and availability may be jeopardised . Cybersecurity must evolve alongside these technologies to enable innovation.
Healthcare and lifescience organisations operate under stringent regulations. Frameworks such as the HIPAA Privacy Rule, GDPR, NIS 2, HITRUST CSF and the upcoming EU AI Act impose requirements for protecting personal and health information . Noncompliance can lead to enforcement actions, costly litigation and reputational harm . Our experts help you build programmes that align with international and local regulations, demonstrating accountability to patients, regulators and partners.
Research ecosystems rely on contract research organisations, sequencing laboratories, cloud providers and device manufacturers. Cyber incidents at a thirdparty vendor can quickly become your problem . Lifescience supply chains are global and highly interconnected ,which increases vulnerability to disruption. Robust vendor risk management, contractual safeguards and continuous monitoring are critical.
Many breaches begin with phishing, social engineering or configuration errors. In the first half of 2022 there were 2.8 billion malware attacks and 236.1 million ransomware attacks, and by yearend nearly six billion phishing attacks were expected . Training all staff – not just IT teams – to recognise and respond to suspicious activity, and integrating cybersecurity into everyday processes, help reduce humanfactor risk.
Regulators and insurers recommend periodic privacy and security risk assessments . Identifying where sensitive data resides, assessing vulnerabilities in clinical systems and laboratories, and modelling potential impact will help prioritise remediation efforts and guide investment. Having a rehearsed incident response plan ensures rapid action when events occur.
How Iliomad Health Data Can Help You
Our cybersecurity team combines deep lifescience domain knowledge with technical expertise and regulatory experience. We partner with research institutions, biotech and medtech companies, CROs and hospital innovation teams to build resilient operations.
